Meds A-Z

Cefovecin Sodium

Detailed information about Cefovecin Sodium

Official label facts Owner quick guide first Marketing clearly labeled

Talk to a Vet / Find a Vet Near You Start Symptom Intake

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Add to My Pet's Meds

Choose a pet, confirm current or past, and optionally add reminder notes.

Reviewed / Updated / Sources

Reviewed: Not available

Updated: February 12, 2026, 10:44 PM UTC

Sources:

FDA application profile · official_label
FDA application profile · official_label
Medication usage source · fda_animal_drugs
openFDA case USA-USFDACVM-2025-US-046303 · adverse_reaction
FOI · document

Pet Owner Quick Guide

Start here first for the simple next-step summary.

Used for:

For the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G).

What to watch for:

For subcutaneous use in dogs and cats only
Maximum treatment should not exceed 2 injections
Low blood pressure (1 reports)
Local erythema (1 reports)
Lack of efficacy - NOS (1 reports)

When to call the vet:

Repeated vomiting or diarrhea.
Severe lethargy (hard to wake, very low energy).
Collapse or fainting.
Trouble breathing.
Facial swelling or hives.
Blood in vomit or stool.

Regulatory restrictions are shown in Vet View.

What to ask your vet today:

Is this medicine the right fit for my pet’s current symptoms?
Which warning signs mean I should call back right away?
How should I handle missed doses or refusal to take the medicine?

Safety & side effects

What to watch:

For subcutaneous use in dogs and cats only
Maximum treatment should not exceed 2 injections
Low blood pressure
Local erythema
Lack of efficacy - NOS

Most reported reactions:

Low blood pressure (1 reports)
Local erythema (1 reports)
Lack of efficacy - NOS (1 reports)

When to call your vet:

Repeated vomiting or diarrhea.
Severe lethargy (hard to wake, very low energy).
Collapse or fainting.
Trouble breathing.

Talk to a Vet / Find a Vet Near You Start Symptom Intake

Data freshness: source data appears current.

Latest refresh: Mar 21, 2026, 10:02 a.m.

Data freshness

Medication catalog: Source Roxee | Refreshed Feb 12, 2026, 10:44 PM UTC
Animal Drugs @ FDA: Source FDA | Refreshed Mar 21, 2026, 10:00 AM UTC
Applications/products are imported from FDA export data.
Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Mar 21, 2026, 10:01 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
openFDA reaction terms: Source FDA openFDA | Refreshed Mar 21, 2026, 10:02 AM UTC
openFDA case summaries: Source FDA openFDA | Refreshed Feb 9, 2026, 3:20 AM UTC

Image coming soon

Cefovecin Sodium

Drug type: Generic ingredient • Branded profile • FDA branded products available

Species: Both

Manufacturer: Not available (source)

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both

Manufacturer: Not available

Form: Lyophilized powder for injection, Powder

Identifiers:

ANADA: 200812 NADA: 141285 NDC Package: 17033-002-01 NDC Package: 54771-1520-1 NDC Product: 17033 NDC Product: 54771

Source metadata:

https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200812 · official_label · FDA application profile
https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/141285 · official_label · FDA application profile
https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source

Warnings / Contraindications

Federal law restricts this drug to use by or on the order of a licensed veterinarian. For subcutaneous use in dogs and cats only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Maximum treatment should not exceed 2 injections. For subcutaneous use in dogs and cats only.

High: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For subcutaneous use in dogs and cats only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Maximum treatment should not exceed 2 injections. For subcutaneous use in dogs and cats only.

Source metadata:

https://animaldrugsatfda.fda.gov · fda_animal_drugs · Contraindication source

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Tap or hover a reaction to see what it means in plain language.

Tracked signals

Reported cases

Serious reports

Species represented

Grouped by Body System

Digestive (3) · Loss of appetite, Diarrhea, Decreased appetite Skin & allergy (2) · Hives, Facial swelling (possible allergy) Neurologic (2) · Unsteady walking (ataxia), Tiredness (lethargy) Effectiveness (1) · Lack of efficacy - NOS Other (24) · Low blood pressure, Local erythema, Ketosis

Most Reported Reactions

Body system	Cases	Species	Serious cases
Other	1	Dog	1
Other	1	Dog	1
Effectiveness	1	Dog	1
Other	1	Dog	1
Other	1	Dog	1
Other	1	Dog	1
Skin & allergy	1	Dog	1
Other	1	Dog	1

Species coverage: Dog (21) Cat (11)

View detailed reaction table

Body system	Species	Seriousness	Frequency	Reports
Neurologic	Cat	Non-serious	-	1
Neurologic	Dog	Non-serious	-	1
Other	Dog	Serious	-	1
Digestive	Cat	Non-serious	-	1
Other	Dog	Serious	-	1
Effectiveness	Dog	Serious	-	1
Other	Cat	Non-serious	-	1
Other	Dog	Serious	-	1
Other	Cat	Non-serious	-	1
Other	Cat	Non-serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Skin & allergy	Dog	Serious	-	1
Other	Cat	Non-serious	-	1
Other	Cat	Non-serious	-	1
Other	Dog	Serious	-	1
Skin & allergy	Dog	Serious	-	1
Other	Cat	Non-serious	-	1
Other	Cat	Non-serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Non-serious	-	1
Digestive	Dog	Non-serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Digestive	Cat	Non-serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Cat	Non-serious	-	1
Other	Dog	Serious	-	1

Source metadata:

https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2025-US-046303

Documents

Owner handouts and official technical documents are grouped for faster access.

Owner handouts (0)

No owner handouts linked yet.

Official label / PI (0)

No official label or package insert links yet.

SPL (2)

Cefovecin Sodium for Injection · SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/17466/Cefovecin%20Sodium%20for%20Injection
Convenia® · SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/171/Convenia%C2%AE

FOI (2)

FOI Summary oA 200-812 Approved June 24, 2025.pdf · FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/17145
ucm062340.pdf · FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/849

Source metadata:

https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/17145 · document · FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/17466/Cefovecin%20Sodium%20for%20Injection · document · SPL
https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/849 · document · FOI
https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/171/Convenia%C2%AE · document · SPL

Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness

Medication catalog: Source Roxee | Refreshed Feb 12, 2026, 10:44 PM UTC
Animal Drugs @ FDA: Source FDA | Refreshed Mar 21, 2026, 10:00 AM UTC
Applications/products are imported from FDA export data.
Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Mar 21, 2026, 10:01 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
openFDA reaction terms: Source FDA openFDA | Refreshed Mar 21, 2026, 10:02 AM UTC
openFDA case summaries: Source FDA openFDA | Refreshed Feb 9, 2026, 3:20 AM UTC

Official (FDA)

Identity: Generic ingredient • FDA branded products available

Official FDA brands: Cefovecin Sodium for Injection Convenia®

Case-reported brands (openFDA): MSK

Catalog species: Both • FDA-labeled species: Cat, Dog

Rx/OTC: RX

Form/route: Lyophilized powder for injection, Powder • Subcutaneous

Applications: ANADA 200-812 • NADA 141-285

Documents: 2 (FOI: 2) • SPL: 2 • Label highlights • Official documents

Safety (openFDA)

Top reactions: Dog 14 • Cat 19 • View

Case summaries: 10 (showing 8) • View

openFDA reports are unverified and do not prove causation.

Explore

Related conditions: Abscesses (cat bite abscess) Pyoderma (superficial/deep)

Linked using: Fda_Label (0.95), Fda_Label (0.95)

Diagnosis Codes

Diagnosis-code mappings are not available for this medication yet.

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Owner-facing counseling points

Federal law restricts this drug to use by or on the order of a licensed veterinarian. For subcutaneous use in dogs and cats only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Maximum treatment should not exceed 2 injections. For subcutaneous use in dogs and cats only. (Contraindication, High)

Top reaction signals

Low blood pressure (1) Local erythema (1) Lack of efficacy - NOS (1) Jaundice (1) Hypokalaemia (1) Hyperpigmentation (1) Hives (1) Glomerulonephritis (1)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers

ANADA: 200812 NADA: 141285 NDC Package: 17033-002-01 NDC Package: 54771-1520-1 NDC Product: 17033 NDC Product: 54771

Package NDC	Product NDC	Form / Route	Status
17033-002-01	17033		-
54771-1520-1	54771		-

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

FOI Summary oA 200-812 Approved June 24, 2025.pdf • FOI summary • Official • July 1, 2025
FDA FOI summary for application 200812
ucm062340.pdf • FOI summary • Official • Oct. 2, 2017
FDA FOI summary for application 141285

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 5 Clinical 0 Manufacturer 0 Marketing 0

Current Field Facts

contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For subcutaneous use in dogs and cats only. Federal law restricts this dr… (Official, 2026-02-12)
side_effects: Top reported reactions (openFDA): Vomiting, Corneal ulcer, Other abnormal test result NOS, Diarrhoea, Lethargy (see also Central nervous system depression in '… (Official, 2026-02-12)
usage: For the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida . For the treatment of skin infectio… (Official, 2026-02-12)

Recent Revisions

side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product	Sponsor	Application	Status	Published
Cefovecin Sodium for Injection RX Cefovecin sodium Lyophilized powder for injection • Subcutaneous Label highlights Official documents	Qilu Animal Health Products Co., Ltd.	ANADA 200-812	Approved	Jul 1, 2025
Convenia® RX Cefovecin sodium Powder • Subcutaneous Label highlights Official documents	Zoetis Inc.	NADA 141-285	Approved	Oct 2, 2017

Data source: FDA Animal Drugs @ FDA (public search export).

What It's For (FDA Label Highlights)

Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.

Composition / specifications

Each mL of reconstituted lyophile contains 80 mg of cefovecin as the sodium salt

Dogs

Indication

For the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G).

Dosage

Administer 3.6 mg/pound (lb) (8 mg/kilograms (kg)) body weight as a single subcutaneous injection. A second subcutaneous injection of 3.6 mg/lb (8 mg/kg) may be administered if response to therapy is not complete.

Limitations

Cats

Indication

For the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida.

Dosage

Administer 3.6 mg/lb (8 mg/kg) body weight as a single, one-time subcutaneous injection.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied

Composition / specifications

Each milliliter of constituted solution contains 80 milligrams cefovecin as the sodium salt.

Cats

Indication

For the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida.

Dosage

Administer 3.6 mg/lb (8 mg/kg) body weight as a single, one-time subcutaneous injection.

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian. For subcutaneous use in dogs and cats only.

Dogs

Indication

For the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G).

Dosage

Administer 3.6 mg/lb (8 mg/kg) body weight as a single subcutaneous injection. A second subcutaneous injection of 3.6 mg/lb (8 mg/kg) may be administered if response to therapy is not complete.

Limitations

Federal law restricts this drug to use by or on the order of a licensed veterinarian. Maximum treatment should not exceed 2 injections. For subcutaneous use in dogs and cats only.

FDA page: Open in Animal Drugs @ FDA

Official Documents (FDA)

Direct links to FDA-hosted PDFs and SPL packages (when available).

Documents

FOI FOI Summary oA 200-812 Approved June 24, 2025.pdf

Summary

Dogs:Â For the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G).
Cats:Â For the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida.

SPL Packages

Cefovecin Sodium for Injection (ZIP)

FDA page: Open in Animal Drugs @ FDA

Documents

FOI ucm062340.pdf

Summary

For the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida.

SPL Packages

Convenia® (ZIP)

FDA page: Open in Animal Drugs @ FDA

Usage

For the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida . For the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G).

Source: FDA Animal Drugs @ FDA • Reference

Contraindications

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Digestive

Loss of appetite (1) • Cat Diarrhea (1) • Dog Decreased appetite (1) • Cat

Showing top 5 for Digestive.

Skin & allergy

Hives (1) • Dog Facial swelling (possible allergy) (1) • Dog

Showing top 5 for Skin & allergy.

Neurologic

Unsteady walking (1) • Cat Tiredness (1) • Dog

Showing top 5 for Neurologic.

Effectiveness

Lack of efficacy - NOS (1) • Dog

Showing top 5 for Effectiveness.

Other

Low blood pressure (1) • Dog Local erythema (1) • Dog Ketosis (1) • Cat Jaundice (1) • Dog Intentional misuse (1) • Cat

Show more (19)

Hypothermia (1) • Cat Hypokalaemia (1) • Dog Hyperpigmentation (1) • Dog Hiding (1) • Cat Gum disorder NOS (1) • Cat Glomerulonephritis (1) • Dog Elevated temperature (1) • Cat Dysphoria (1) • Cat Drinking a lot (1) • Dog Discomfort NOS (1) • Dog Delayed healing (1) • Dog Delayed fracture union (1) • Dog Decreased percentage of reticulocytes (1) • Dog Death by euthanasia (1) • Dog Death (1) • Dog Autoimmune disorder NOS (1) • Dog Anaphylactic-type reaction (1) • Dog Abnormal radiograph finding (1) • Cat Abnormal cytology (1) • Dog

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Cat, Domestic Shorthair, Female, 18 year, 2.51 kilogram • Drug: MSK, Unknown • Reactions: Not sleeping, Dysphoria • Outcome: Outcome Unknown

Report ID: USA-USFDACVM-2025-US-056122
Serious AE: No
Treated For AE: No
Sex: Female
Age: 18.00 Year
Weight: 2.510 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown

Reactions Reported:

Not sleeping Dysphoria

Outcomes: Outcome Unknown

Cat, Domestic Shorthair, Male, 6 year, 6.35 kilogram • Drug: MSK, Unknown • Reactions: Elevated temperature, Decreased appetite, Weight loss, Gum disorder NOS • Outcome: Ongoing

Report ID: USA-USFDACVM-2025-US-055975
Serious AE: No
Treated For AE: No
Sex: Male
Age: 6.00 Year
Weight: 6.350 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown

Reactions Reported:

Elevated temperature Decreased appetite Weight loss Gum disorder NOS

Outcomes: Ongoing

Cat, Domestic Mediumhair, Female, 13 year, 2.858 kilogram • Drug: MSK, Subcutaneous, Dose: 0.30 mL per animal • Reactions: Tiredness (lethargy), Unresponsive to stimuli, Not eating, Not drinking, Hiding… • Outcome: Ongoing

Report ID: USA-USFDACVM-2025-US-055801
Serious AE: No
Treated For AE: Yes
Sex: Female
Age: 13.00 Year
Weight: 2.858 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Subcutaneous
Dose: 0.30 mL per animal

Reactions Reported:

Tiredness (lethargy) Unresponsive to stimuli Not eating Not drinking Hiding Unsteady walking (ataxia) Abnormal radiograph finding Hypothermia Tympanic opacity Weight loss Malaise Muscle weakness NOS Intentional misuse Lack of efficacy - NOS

Outcomes: Ongoing

Cat, Cat (unknown), Female, 12 year, 3.44 kilogram • Drug: MSK, Unknown • Reactions: Tiredness (lethargy), Loss of appetite • Outcome: Ongoing

Report ID: USA-USFDACVM-2025-US-055698
Serious AE: No
Treated For AE: No
Sex: Female
Age: 12.00 Year
Weight: 3.440 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown

Reactions Reported:

Tiredness (lethargy) Loss of appetite

Outcomes: Ongoing

Cat, Domestic Mediumhair, Female, 16 year, 4.5 kilogram • Drug: MSK, Unknown • Reactions: Ketosis • Outcome: Outcome Unknown

Report ID: USA-USFDACVM-2025-US-054426
Serious AE: No
Treated For AE: No
Sex: Female
Age: 16.00 Year
Weight: 4.500 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown

Reactions Reported:

Ketosis

Outcomes: Outcome Unknown

Dog, Terrier - Yorkshire, Male, 8 year, 3.629 kilogram • Drug: MSK, Injection, Subcutaneous, Dose: 32 Milligram per dose, Frequency: 1 per day • Reactions: Jaundice, Low blood urea nitrogen, Low creatinine, Hypokalaemia, Death by euthanasia • Outcome: Euthanized

Report ID: USA-USFDACVM-2025-US-053982
Serious AE: Yes
Treated For AE: Yes
Sex: Male
Age: 8.00 Year
Weight: 3.629 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Subcutaneous
Form: Injection
Dose: 32 Milligram per dose
Frequency: 1 per day

Reactions Reported:

Jaundice Low blood urea nitrogen Low creatinine Hypokalaemia Death by euthanasia

Outcomes: Euthanized

Dog, Crossbred Canine/dog, Female, 12 year, 10.886 kilogram • Drug: MSK, Unknown • Reactions: Vomiting, Discomfort NOS, Not sleeping, Whining, Not eating… • Outcome: Ongoing

Report ID: USA-USFDACVM-2025-US-051294
Serious AE: No
Treated For AE: No
Sex: Female
Age: 12.00 Year
Weight: 10.886 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown

Reactions Reported:

Vomiting Discomfort NOS Not sleeping Whining Not eating Diarrhea Tiredness (lethargy)

Outcomes: Ongoing

Dog, Poodle - Toy, Male, 4.5 year, 4.54 kilogram • Drug: MSK, Unknown • Reactions: Polyuria, Urinary incontinence • Outcome: Outcome Unknown

Report ID: USA-USFDACVM-2025-US-048414
Serious AE: No
Treated For AE: No
Sex: Male
Age: 4.50 Year
Weight: 4.540 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown

Reactions Reported:

Polyuria Urinary incontinence

Outcomes: Outcome Unknown

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

No community reviews yet. Be the first to share your experience.

This medication has not been reviewed by a veterinarian yet.

Medical Disclaimer: The medication details provided on Roxee are for informational purposes only and are not a substitute for professional veterinary advice. Always consult your veterinarian about your pet's specific needs.

Cefovecin Sodium

Add to My Pet's Meds

Reviewed / Updated / Sources

Pet Owner Quick Guide